About US
Contact us
-
FDA official encourages makers of Low T drugs to work together on a single risks trialWhile data on the heart and stroke risks oftestosteroneenhancers have been mixed, theFDAhas held firm on its position that "Low T" drugs should be used only for medical conditions and not as a lifesty2015/8/21
-
CFDA Vice Minister Wu Zhen meets the delegation of Kenya's National Assembly Departmental Committee on HealthOn the afternoon of August 12, 2015, Wu Zhen, Vice Minister of China Food and Drug Administration (CFDA), met with the delegation of Kenya's National Assembly Departmental Committee on Health headed b2015/8/20
-
Amgen wraps up Aranesp, Enbrel marketing probe with $71M state-level settlementAmgen ($AMGN) is paying up to resolve claims that it broke the rules while marketing anemia drugAranespand anti-inflammatory blockbusterEnbrel. The company has settled with 48 states for $71 million,2015/8/20
-
Horizon puts forth its slate of new Depomed directorsHorizon ($HZNP) has criticized Depomed's ($DEPO) directors for refusing to come to the table, despite its attempts to "engage in good faith" over a combination of the two companies. Now, though, it's2015/8/20
-
FDA hammers Mylan sterile injectable plants for serious contamination issuesThe recent recall of 8 lots of injectable cancer drugs, some of which Mylan ($MYL) made for client Pfizer ($PFE), was just a prelude to anFDAwarning letter, it turns out. The agency today posted the l2015/8/19
-
Matchmaking investors pick Biogen, Pfizer as fave Allergan deal partnersWho should serial buyer Allergan ($AGN) pick up next? It's the question on the minds of many industry watchers--including Evercore ISI analyst Umer Raffat, who polled investors last week. And while th2015/8/19
-
Will docs jump on new biosims? Survey shows they'll need some nudgingDrugmakers are well aware of the biosimilars threatening to steal sales and market share from some of the world's best-selling biologics. Doctors, though? Not so much, a new report suggests. Doctor2015/8/18
-
Mylan, Disney expand allergy-fighting partnership with new websiteParents whose children have potentially life-threatening allergies now have some new resources--thanks to Mylan ($MYL) and Disney ($DIS), which have teamed up to launchMyAllergyKingdom.com. There, the2015/8/18
-
FDA approves Purdue's OxyContin for use in youth aged 11 to 16The addictive qualities of the powerful pain drugOxyContinhave made it controversial, but theFDAhas now approved it for youth 11 to 16 after asking makerPurdue Pharmato study its use in that age group2015/8/17
-
Probing lawmakers grill Valeant on price hikesA pair of lawmakers is taking a look into recent drug price increases--and as part of the investigation, it wants some information from Valeant. On Friday, Rep. Elijah Cummings (D-MD) and Sen. Bernie2015/8/17